Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer.
Arlene E Garcia-SotoNathalie D McKenzieMargaret E WhickerJoseph M PearsonEdward A JimenezLorraine PortelanceJennifer J HuJoseph A LucciRehman QureshiAndrew V KossenkovLauren SchwartzGordon B MillsAmit MaityLilie L LinFiona SimpkinsPublished in: Cancer (2021)
NFV with CRT is well tolerated. The response rate is promising compared with historic controls in this patient population and warrants further investigation.